Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Clinical trial NCT04137107 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04137107
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2026-02-28
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.